RIVIECCIO, ANTONIA
RIVIECCIO, ANTONIA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.001 secondi).
Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis
2024-01-01 Campione, E; Zarabian, N; Cosio, T; Borselli, C; Artosi, F; Cont, R; Sorge, R; GAETA SHUMAK, R; Costanza, G; Rivieccio, A; Gaziano, R; Bianchi, L
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
2023-01-01 Campione, E; Rivieccio, A; Gaeta Shumak, R; Costanza, G; Cosio, T; Lambiase, S; Garofalo, V; Artosi, F; Lozzi, F; Freni, C; Romeo, A; Dika, E; Falconi, M; Bianchi, L
Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway
2024-01-01 Belardi, R; Pacifici, F; Cosio, T; Lambiase, S; GAETA SHUMAK, R; Artosi, F; Rivieccio, A; Cavalloro, D; Dellambra, E; Bianchi, L; Della-Morte, D; Campione, E
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2024 | Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Patients with Psoriasis: An Observational Analysis | Campione, E; Zarabian, N; Cosio, T; Borselli, C; Artosi, F; Cont, R; Sorge, R; GAETA SHUMAK, R; Costanza, G; Rivieccio, A; Gaziano, R; Bianchi, L | Articolo su rivista | |
1-gen-2023 | Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses | Campione, E; Rivieccio, A; Gaeta Shumak, R; Costanza, G; Cosio, T; Lambiase, S; Garofalo, V; Artosi, F; Lozzi, F; Freni, C; Romeo, A; Dika, E; Falconi, M; Bianchi, L | Articolo su rivista | |
1-gen-2024 | Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway | Belardi, R; Pacifici, F; Cosio, T; Lambiase, S; GAETA SHUMAK, R; Artosi, F; Rivieccio, A; Cavalloro, D; Dellambra, E; Bianchi, L; Della-Morte, D; Campione, E | Articolo su rivista |